Week of July 26 - August 1, 2015
OncoLink eNews July/August 2015
Receive cutting-edge information from some of the foremost cancer authorities from the University of Pennsylvania, delivered to your email.
Lenvatininb (Lenvima) is a VEGF tyrosine kinase inhibitor used in the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC).
Palbociclib (Ibrance®) is an oral therapy for postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer.
Panobinostat (Farydak ®) is an oral chemotherapy given in combination with other medications for the treatment of several types of cancers.
OncoLink's blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Don’t Assume You Understand
by Bob Riter
Homeopathy: What You Should Know
by The 4Wholeness Team
OncoLink Survey: Do you have a Personal Emergency Kit?
by OncoLink Editorial Team
Retired Nurses and Their Memories of Cancer
by Bob Riter
National Cancer Survivors Day 2015 Wrap Up
by Carolyn Vachani, MSN, RN, AOCN
See all recent posts [RSS]
I Wish You Knew
3D Mammography: What is it?
Blogs and Web Chats
OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!